Waldencast (NASDAQ:WALD) PT Lowered to $8.00 at Telsey Advisory Group

Waldencast (NASDAQ:WALD) had its target price reduced by Telsey Advisory Group from $10.00 to $8.00 in a research report report published on Wednesday morning, MarketBeat reports. They currently have an outperform rating on the stock.

Waldencast Trading Up 3.7 %

WALD stock opened at $5.05 on Wednesday. The stock has a 50-day moving average price of $6.38 and a two-hundred day moving average price of $8.15. Waldencast has a 1 year low of $4.71 and a 1 year high of $12.00.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in WALD. Zeno Equity Partners LLP acquired a new stake in shares of Waldencast during the 4th quarter valued at $224,278,000. Truxt Investmentos Ltda. lifted its holdings in Waldencast by 3.7% in the fourth quarter. Truxt Investmentos Ltda. now owns 4,075,479 shares of the company’s stock valued at $44,586,000 after buying an additional 144,841 shares during the period. Bank of New York Mellon Corp grew its stake in Waldencast by 73.6% during the third quarter. Bank of New York Mellon Corp now owns 86,409 shares of the company’s stock worth $814,000 after purchasing an additional 36,642 shares during the period. Simplicity Wealth LLC bought a new stake in shares of Waldencast in the 1st quarter valued at $142,000. Finally, SG Americas Securities LLC acquired a new position in shares of Waldencast during the third quarter valued at about $151,000. 41.97% of the stock is currently owned by institutional investors and hedge funds.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.